John Lubniewski Insider Profile
4 Followers
John Lubniewski, President & CEO, Director at HTG Molecular Diagnostics, holds 14.13K shares in HTG Molecular Diagnostics (Ticker: HTGMQ).
John Lubniewski's Trading History
| HTGMQHTG Molecular Diagnostics | Dec 13, 2022 | President & CEO, Director | Uninformative Buy | 420.00 | ― | |
HTGMQ Insider Shares: 14.13K (0.13%) | ||||||
You May Also Like
John Lubniewski insider profile FAQ
What stocks does John Lubniewski hold?
John Lubniewski holds: HTGMQ stocks.
What was John Lubniewski’s latest transaction?
John Lubniewski’s latest transaction was an Uninformative Buy of $420.00.
What is John Lubniewski's role in HTG Molecular Diagnostics?
John Lubniewski's role in HTG Molecular Diagnostics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
